Article Details
Retrieved on: 2024-05-08 13:50:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the impact of RSV, a serious respiratory virus, in comparison to COVID-19, and highlights the approvals of monoclonal antibody treatments (Nirsevimab) and vaccines (Abrysvo and Arexvy) to combat the virus, especially in infants and older adults.
Article found on: www.tucsonlocalmedia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here